AllDocs -> cancers

Questions And Answers About Sex And Prostate Cancer Men who have cancer of the prostate usually have questions or concerns about the effects this cancer or treatment may have on their sexuality. This handout gives answers to some commonly asked questions. You may have had surgery, radiation therapy, brachytherapy, chemotherapy or hormone therapy to treat your cancer . These treatments may affect how you feel about yourself and your sexuality. Sexuality is more than the act of sexual intercourse (sex). It involves your thoughts, feelings and your spirituality. Remember that your sexuality is unique to you. Some of this information may not apply to you. Please discuss concerns with a member of your health care team. Dr. Leslie R. Schover discusses other questions and concerns in the booklet, Sexuality and Cancer , For the Man Who Has Cancer and His Partner. The American Cancer Society ...

Visualizing Prostate Cancer Patients Treated with Three- Dimensional Computed Tomography-Guided Brachytherapy Jee Vang Faleh Al-Shameri May 5, 2003 Page 2 Background on Prostate Cancer Most common cancer among US men In year 2002 189,000 US men diagnosed with prostate cancer (of which) 30,200 died from prostate cancer Risk factors Age: White male over 50, Black male at 40 Race: Black male have incidence 1.5 times white male (China and Japan lowest) Family History: Male with first-degree relative with prostate cancer has twice increased risk for prostate cancer Page 3 Clinical Indicators of Prostate Cancer Prostate -specific antigen (PSA) Continuous value (above 0.0) Gleason’s score Whole numbers (1 – 10) Stage ...

A fact sheet from the Greater Bay Area Cancer Registry Prostate Cancer in the Greater San Francisco Bay Area 1988-2000 Spring 2004 In men, prostate cancer is the most common type of cancer diagnosed, comprising almost a third of all cancer cases. Nearly 50,000 men were diagnosed with prostate cancer in the Greater Bay Area during the period 1988-2000, an average of 4,000 cases per year. Prostate cancer is also a leading cause of cancer death in men, second only to lung cancer . Figure 1. Age-adjusted incidence and mortality rates forprostate cancer by year of diagnosis, Greater San Francisco Bay Area, 1988-2000 Figure 2. Age-adjusted prostate cancer incidence by race/ethnicity, Greater San Francisco Bay Area, 1988-2000 0 25 50 75 100 125 150 175 200 225 1988 1989 1990 ...

High Intensity Focused Ultrasound for Prostate Cancer : Clinical Results and Technological Evolution John C. Rewcastle, Ph.D. Department of Radiology University of Calgary, Alberta, Canada Prostate cancer is responsible for 9% of cancer related death in European men (Black et al 1997) and it is estimated that each year there will be approximately 85,000 new cases of prostate cancer diagnosed in the European Union (Jensen et al 1990). Strategies for managing prostate cancer include deferred treatment (watchful waiting), radical prostatectomy, definitive radiation therapy and hormone therapy. Deferred treatment is utilized in patients who are expected to die of causes other than prostate cancer based on the age and health of the patient and the characteristics of their disease. Hormone therapy can delay but not stop the progression of prostate cancer and is used when the cancer ...

Red Wine May Keep Prostate Cancer Cells in Check Tue Jul 9,12:31 PM ET NEW YORK (Reuters Health) - Compounds in red wine may keep prostate cancer cells from proliferating, results of a preliminary laboratory study suggest. Researchers from Spain found five different polyphenols--antioxidants found in red wine, tea, and certain fruits and vegetables--inhibited the growth of prostate cancer cells in a test tube and encouraged cancer cells to "commit suicide"--a natural process called apoptosis. The findings, if confirmed by larger studies, may help to explain the higher rates of prostate cancer in the US and non-Mediterranean European countries, according to Dr. I. Romero and colleagues from Getafe University in Madrid, Spain. The rate of prostate cancer in Mediterranean countries, where intake of red wine and other polyphenol- containing foods is high, tends to be lower. ...

RADIATION THERAPY for PROSTATE CANCER Non-Surgical Options Facts to Help Patients Make An Informed Decision RISK FACTORS FOR PROSTATE CANCER Incidence of prostate cancer increases with age. ¢ Median age at diagnosis in Caucasian males is 71. ¢ African-American men have the highest incidence of prostate cancer in the world. ¢ Heredity accounts for 5 to 10 percent of cases. HELPFUL WEB SITES ON PROSTATE CANCER ASTRO THE AMERICAN SOCIETY FOR THERAPEUTIC RADIOLOGY AND ONCOLOGY 12500 Fair Lakes Circle, Suite 375 Fairfax, VA 22033-3882 Phone: 1-800-962-7876 • 703-502-1550 Fax: 703-502-7852 www.astro.org FACTS ABOUT PROSTATE CANCER Prostate cancer is the most common malignancy in American men. ¢ In 2003, more than 220,000 men were diagnosed ...

The PSA Decision Is testing for prostate cancer right for you? Created by Stacey L. Sheridan, MD, MPH , Michael P. Pignone, MD, MPH, and Russell P. Harris, MD, MPH Division of General Medicine University of North Carolina at Chapel Hill Funding Source: University Research Council Small Grant from the Lineberger Comprehensive Cancer Center Fincancial Conflicts: None Page 2 The PSA Decision The prostate is located under the urinary bladder. Prostate Bladder Doctors disagree about whether having a test to look for prostate cancer is a good idea. Much of the disagreement is due to how much weight or value each doctor places on the information we know about prostate cancer and the testing process. These cards will give you information about the following topics: ...

103 Proclamations Proc. 7700 before we can reliably detect the disease in its earliest stages when treat- ment is most effective. I urge all women to talk to their doctors about ovar- ian cancer and the best course of action to detect and treat this deadly dis- ease. Doing so is particularly important for women aged 40 or older, those with a family history of ovarian cancer , and those with a personal history of breast, endometrial, or colon cancer . And I urge individuals across the country to learn more about this disease and what can be done to reduce the number of individuals who suffer from it. In addition to encouraging early detection and increasing awareness about ovarian cancer , we must continue to advance our knowledge through re- search. Scientists at the Centers for Disease Control and Prevention, the Na- tional Cancer Institute, the Department of Defense, the Food and ...

FY03 Prostate Cancer Research Program Peer Reviewers Abdel-Mageed, Asim D.V.M., Ph.D. Department of Urology, Tulane University Health Sciences Center Adkison, Linda Ph.D. Division of Basic Medical Sciences, Mercer University School of Medicine Ahaghotu, Chiledum M.D. F.A.C.S Department of Surgery, Howard University Hospital Ahmed, Mansoor Ph.D. Department of Radiation Medicine, University of Kentucky Medical Center Arlen, Philip M.D. Laboratory of Tumor Immunology & Biology, NIH, National Cancer Institute Bahnson, Robert M.D. Division of Urology, Ohio State University College of Medicine Balk, Steven M.D., Ph.D. Hematology Oncology Division, Beth Israel Deaconess Medical Center Bartlett, Darrell American Cancer Society Batra, Surinder Ph.D. Dept of Biochemistry and Molecular Biology, ...

Indian Journal of Clinical Biochemistry, 2004 62 aspiration cytology (6). Advocates of prostate cancer screening argue that PSA measurement would help to select an at risk group while transurethral ultrasonography (TRUS) and biopsy would identify clinically occult early tumours in this group (6). This article evaluates the performance of serum PSA measurement in patients suspected of having prostate cancer and comparing with histological examination of prostate biopsy specimens. PATIENTS AND METHODS A retrospective study of all patients who were referred to the Chemical Pathology department of Aminu Kano Teaching Hospital, Kano, Nigeria for serum PSA was included in the study. The histopathology Laboratory records and medical records were searched for the patient who’s serum PSA Level was determined between December 2000 and August 2002. The hospital records ...

Research Articles 174 Public Health Reports / March–April 2004 / Volume 119 SYNOPSIS Objective. The purpose of this study was to compare prostate cancer inci- dence and mortality trends between the United States and Canada over a period of approximately 30 years. Methods. Prostate cancer incident cases were chosen from the National Cancer Institute’s Surveillance Epidemiology and End Results (SEER) Program to estimate rates for the United States white males and from the Canadian Cancer Registry for Canadian men. National vital statistics data were used for prostate cancer mortality rates for both countries, and age-adjusted and age-specific incidence and mortality rates were calculated. Joinpoint analysis was used to identify significant changes in trends over time. Results. Canada and the U.S. experienced 3.0% and 2.5% growth in age- adjusted incidence from 1969–90 and ...

Action Plan on Prostate Cancer for the State of Texas Developed by: Texas Medical Association’s Physician Oncology Education Program Andrew Miller, MHSE, CHES Project Director Robin C. Calloway Project Coordinator Debbie Celusniak Graphic Artist This project is a collaboration of these agencies and organizations: American Cancer Society, Texas Division, Inc. Texas Cancer Council Texas Department of Health Texas Medical Association Funded by the Centers for Disease Control and Prevention, under grant number U55-CCU616039 This report is also available on the Web at: www.tcc.state.tx.us FEBRUARY 2002 TEXAS CANCER COUNCIL Page 2 Page 3 CONTENTS I iii Contents Introduction v Project ...

Your Guide to Your Guide to Prostate Cancer Prostate Cancer Treatment and Health Treatment and Health Michigan Urology Center At the University of Michigan Comprehensive Cancer Center Page 2 Introduction Introduction Our goals Our goals Our ultimate goal is to partner with you in improving and maintaining your health, that’s why we’ve produced this guidebook for you and your family. We hope it will prove to be a valuable resource as we embark on this journey together. How this guide will work for you How this guide will work for you This guidebook is designed to provide answers to commonly asked questions, explain the various phases of treatment of prostate conditions, and provide helpful resources to support you and your loved ...

ABSTRACT Surviving Prostate Cancer and Treatment: Impact on Couples Michael E. Galbraith, PhD, RN, Loma Linda University Purpose: The purpose of this study was to a) compare health status, health-related quality of life, and treatment symptoms among extended survivors of prostate cancer who have received different doses of proton-beam radiation treatment and, b) describe the relationship of health status, health-related quality of life, and marital satisfaction between extended survivors of prostate cancer and their partners. Rationale/Significance of Study: Prostate cancer is the most common diagnosed cancer in men and has immediate and long-term effects. It is estimated there will be 221,900 new cases and 28,900 deaths this year. Men=s partners are also impacted by the diagnosis and treatment of prostate cancer . Conceptual Framework: The framework for this study was constructed ...

PROSTATE Wesley Garrett is a walking testimonial to the value of routine screening for prostate cancer with the prostate -specific antigen (PSA) blood test. When he’s not building oilfield equipment and repairing electric motors, he enjoys fishing, Houston Comets’ games and family outings. Just the Facts Prostate Cancer Your best chance for surviving prostate cancer is detecting it early.When prostate cancer is found early,there is nearly a 100 percent chance for cure. Symptoms There are often no symtoms of prostate cancer in it’s earliest stages.If symptoms are present,they vary from man to man,and may include: • frequent urination • hard time when starting to urinate,or trying to hold it back • not being able to urinate • weak or interrupted urine flow • painful or burning urination • blood in the urine ...

1999 State Added Questions - Prostate Cancer Screening Only ask males greater than or equal to age 50. This next section of questions deals with prostate cancer and screening practices. Next, I'd like to ask you about the PSA or Prostate Specific Antigen blood test. This test is used by some physicians to help detect prostate cancer or to determine how well prostate cancer is responding to treatment. PRO1. Have you ever been told by a physician that you should have a PSA blood test to check for prostate cancer ? Yes 1 No 2 Don=t know/Not sure 7 Refused 9 PRO2. Have you ever had a PSA blood test? Yes 1 No Go to PRO5 2 Don=t know/Not Sure 7 Refused 9 PRO3. How long has it been since your last Prostate Specific Antigen blood test? Within the past year(0-12 months ago) 1 Within the past two ...

DIALOGUE THE CURE STARTS HERE • CAMPAIGN FOR THE FUTURE FALL/WINTER 2003 3-D Imaging, Robotic System Enhances Precision for Prostate Cancer Surgery Surgeons at Strong Memorial Hospital and the James P.Wilmot Cancer Center are the first in upstate New York to use high-tech robotic systems to ensure greater precision while performing surgery to remove cancerous prostate tumors.This technology provides surgeons a three-dimensional view, giving them the feel of an open surgery while performing a minimally invasive procedure. “This system truly enhances the images and is dramatically better,” says Jean V. Joseph, M.D., urology surgeon. “The magnified 3-D images improve the accuracy and precision.” Strong recently added the daVinci Surgical System to expand laparascopic procedures in urology and cardiac surgery. The leading-edge ...

Bt(mansþIGMBICmáWmharIkRbesþt ( Prostate Cancer ) etICmáWmharIkRkeBjRbesþtKWCaGVI/ RbesþtmanTMhMubunEpø½lNat (walnut) manEtburseTEdlman. ehIyvaenAxageRkamtRmg enam nigxagmuxcugeBaHev[nZM. bursCnCatiGasIu nigbursmkBIekaHenAsmuRT:sIuhVikCa eRcIn EtgEtekItCmáWmharIkRbesþt. mankarBinitüeZVIEtsþmYycMnYn EdlGacCYyorkeXIj CmáWmharIkRbesþt enAeBlEdlvaeTIbEtekItmanzÍµ>. buEnþeyIgk*min:ndwgoBitR:kdza÷ kareZVIeraKvínicä&yrkeXIjCmáWenAeBlEdlvaeTIbEtcabepþÍmekItman GacCYybeg,ÍnnUvGRtao rYcputBIkarsøabedaysarCmáWenHeT. GMBIesckþIsMerccitþ kñúgkareZVIEtsþBinitüCmáWenH va GaRs&yeTAelIxøÜnelakGñkpÞal nigRKÚeBTürbselakGñk. etInrNaxøH GacrgeRKaHedaysarCmáWenH/ • bursTaMgGsEdlmanGayueRcInCag 50qñaM • bursEdlTTYlTanGaharEdlmanCatixøajeRcIn • bursEdlmanRbvtþiRKÜsarZøabekItCmáWmharIkRbesþt karENnaMsMrabkarBinitü; • enAeBlEdlelakGñkmanGayu 50qñaM cUrBiPakSaCam...

Real-Time Elastography for Prostate Cancer Detection: Preliminary Experience Abstract published in "Urology" / Contribution to the RSNA 2003 ------------------------------------------------------------------------------ Authors: Andrea Klauser MD Florian Koppelstaetter MD Wolfgang Horninger MD Andreas Berger MD Andreas Lorenz MD Andreas Pesavento MD Ferdinand Frauscher MD ------------------------------------------------------------------------------ Keywords: Prostate , US Prostate neoplasms Ultrasound (US), tissue characterization ------------------------------------------------------------------------------ Abstract: Purpose : To assess the value of real-time elastography in the detection of prostate cancer . Methods and Materials : Fifteen patients with biopsy proven prostate cancer were studied prior radical prostatectomy. Elastography ...

Regional Health Education Kaiser Permanente Health Matters T he prostate is a walnut-sized gland located in front of the rectum and below the bladder. Next to skin cancer , prostate cancer is the most common type of cancer in men. At some point in their lives, 8 out of 100 men over the age of 50 will have their lives affected by prostate cancer . Of those eight, three will die from prostate cancer . The other five will not have their lives short- ened because most prostate cancers grow very slowly. What are the symptoms of prostate cancer ? Early prostate cancer usually has no symptoms. However, having trouble urinating or urinating more often may be signs of prostate cancer . These symptoms could also simply mean your prostate is enlarged, or they can be signs of other health problems. ...

Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging; a multichannel statistical classifier Ian Chan and William Wells III Surgical Planning Laboratory, Department of Radiology, Division of MRI, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115 and MIT Artificial Intelligence Laboratory, Cambridge, Massachusetts 02139 Robert V. Mulkern Children’s Hospital Department of Radiology, Harvard Medical School, Boston, Massachusetts 02115 Steven Haker and Jianqing Zhang Surgical Planning Laboratory, Department of Radiology, Division of MRI, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115 Kelly H. Zou Surgical Planning Laboratory, Department of Radiology, Division of MRI, Brigham and Women’s Hospital, Harvard Medical School, ...

doi:10.1016/S0360-3016(03)01456-1 EDITORIAL HYPOFRACTIONATION FOR PROSTATE CANCER RADIOTHERAPY—WHAT ARE THE ISSUES? D AVID J. B RENNER , P H .D., D.S C . Department of Radiation Oncology, Center for Radiological Research, Columbia University, New York, NY You can’t open a radiation journal these days without some- one debating the / ratio for prostate cancer (1–17) . An- other interesting contribution appears in this edition of the IJROBP (18) . Why the debate? What are the issues? What might they mean for prostate cancer radiotherapy? In brief, the arguments have gone as follows: 1. One of the main motivations for delivering a treatment in many fractions is that late sequelae are generally more sensitive than early effects (such as tumor control) to changes in fractionation, so increasing the ...

Prostate Cancer What Is The Prostate ? The prostate is a male sex gland, about the size of a walnut. The prostate surrounds the bladder and is in the front of the rectum. Is also surrounds the upper part of the urethra, the tube that empties urine from the bladder. It produces a thick fluid that forms part of semen. The prostate uses testosterone, a male hormone, to function normally. What Are The Signs Of Prostate Cancer ? Early prostate cancer often does not cause signs or symptoms. When signs of prostate cancer do occur, they may include: C Urinating more often, especially at night C Difficulty starting urination or holding back urine C Weak or interrupted flow of urine C Painful or burning urination C Painful ejaculation (release of semen through the penis during ...

LAST NAME __ (PLEASE PRINT) National Conference On Prostate Cancer 2003 Individual Videocassettes $ 15.00 Complete Video Set (14 Videos) $ 175.00 Individual DVDs $ 15.00 Complete DVD Set (14 DVDs) $ 175.00 PC2101 PC 101 – Understanding the Diagnosis and Staging of PC – Charles “Snuffy” Myers MD. Blood Tests – More Than Just PSA - Jonathan E. McDermed,Pharm.D PC2102 Pathology – Defining the Nature of the Disease – David Bostwick, MD, Radical Prostatectomy – Stanley Brosman, MD PC2103 Brachytherapy - IMRT – M ichael. Dattoli, MD, Cryosurgery – Fred Lee, MD PC2104 Androgen Deprivation – A Primary Therapy - Bob Leibowitz, MD, Case Study for Newly Diagnosed – Panel of Doctors Introduction to Patient Resources – Where to Find Help – Panel of Survivors PC2105 Welcome & Sponsor Recognition – Charles “Snuffy” Myers MD, Live Demonstration ...

FOR IMMEDIATE RELEASE CONTACT: Andrew Bright (609) 514 6531 andrew.bright@oncura.com Kristie Kuhl (212) 508-9642 kkuhl@makovsky.com Merger Creates ONCURA, a Global Leader in Minimally Invasive Prostate Cancer Disease Management New York (July 08, 2003) — The merger of Amersham’s (LSE, NYSE, OSE: AHM) brachytherapy business with Galil Medical Ltd’s urology business — originally announced on April 22, 2003 — has been completed. The newly incorporated company named ONCURA will have a major global presence in the treatment of prostate cancer , combining the market leadership of Amersham in brachytherapy with the rapidly growing area of cyrotherapy. Cryotherapy and brachytherapy currently address the needs of different segments of the prostate cancer treatment market. The combination of the leading products in these two segments will position ONCURA as a unique provider ...

Reino Lahtikari Symposium Molecular Targets of Prostate Cancer – from Genetic Basis to Clinical Practice http://www.uta.fi/imt/conferences August 28-29, 2003 Murikka Institute, Tampere, Finland Organizing committee: Johanna Schleutker (chairperson), Anssi Auvinen, Timo Koivula, Paula Martikainen, Pirkko Kellokumpu-Lehtinen, Jaakko Seppänen, Teuvo Tammela, and Tapio Visakorpi Thursday (August 28) 10.05-10.10 Opening Remarks, Johanna Schleutker Session 1 . Genetic Predisposition of Prostate Cancer Chairperson: Tapio Visakorpi, University of Tampere 10.10-11.10 Keynote lecture William B. Isaacs , Johns Hopkins University, Baltimore, MD, USA Inherited Susceptibility and Gene Expression in Prostate Cancer 11.10-11.55 Henrik Grönberg , University of Umeå, Umeå, Sweden Hereditary Prostate Cancer in Sweden ...

Department of Defense US Army Medical Research and Materiel Command Fiscal Year 2001 Prostate Cancer Research Program Awards Book Table of Contents Introduction Fiscal Year 2001 Prostate Cancer Research Program Funded Awards Infrastructure Awards Prostate Cancer Consortium Development Awards Research Awards Prostate Cancer Clinical Trial Awards Health Disparity Research – Prostate Scholar Award Idea Development Awards New Investigator Awards Training/Recruitment Awards Health Disparity Training - Prostate Scholar Awards Historically Black Colleges and Universities Collaborative Partnership Awards Postdoctoral Traineeship Awards Fiscal Year 2001 Prostate Cancer Research Program Participants Peer Reviewers Integration Panel Members Ad Hoc Programmatic ...

FACTS AND FIGURES • Prostate cancer is the most common type of cancer among American males. This year, 232,090 new cases of prostate cancer will be diagnosed and more than 30,350 men will die of the disease. It is the second leading cause of death in men; lung cancer is the first. • Prostate cancer is more commonly diagnosed in African-American men than in white men. Prostate cancer mortality rates are more than two times higher for African-American men than for white men. • Prostate screening consists of a digital-rectal exam and the prostate specific antigen (PSA) blood test, developed by T. Ming Chu, PhD, and colleagues, at Roswell Park Cancer Institute. By feeling the prostate during a digital-rectal exam, doctors can detect unusually firm or irregular areas that may be cancerous. The PSA blood test measures ...

Matt Kaser Christina Kang Joey Steininger BE.105 Prostate Cancer : Abstracts Nanocell Application to Prostate Cancer Over 234,000 men in the United States will be diagnosed with prostate cancer this year. It is the second leading cause of cancer -related deaths in men. Current treatments of prostate cancer such as chemotherapy show drastic side effects including hair loss, nausea, vomiting, infertility, and liver damage. Despite these violent symptoms, the chemotherapy drugs do not cure the cancer , but merely prolong or improve the quality of life. Docetaxel is one of two common chemotherapy drugs discovered in 2004. Docetaxel inhibits cell growth by inducing apoptotic cell death through the cleavage of caspase-3. However, docetaxel also affects normal body cells, which is a cause of side effects. This study proposes a new treatment for prostate cancer using the novel ...